Home>Topics>Funds>iShares Dow Jones US Healthcare

iShares Dow Jones US Healthcare IYH

  1. All
  2. Fund Reports
  3. ETF Reports
  4. Headlines
    1. XLV Health Care Select Sector SPDR ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 22 May 2012

      over the past five years has been an extremely high 99%. Another alternative would be iShares Dow Jones U.S. Health Care IYH (0.47% expense ratio), which holds 120 stocks and sports a 99% performance correlation with XLV over the past five years

    2. PTH PowerShares Dynamic Healthcare ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 8 May 2012

      Sanofi-Aventis SNY. Those who are drawn to PTH for its specific industry tilts might wish to consider iShares Dow Jones US Healthcare Providers Index Fund IHF (0.47%). Investors should note that IHF's underlying index excludes

    3. IHF iShares Dow Jones US Healthcare Provider ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 8 May 2012

      operators like Community Health Systems CYH and Tenet Healthcare THC also are well represented. Suitability IShares Dow Jones US Healthcare Providers Index Fund IHF holds companies that make up much of the backbone of the U.S. health-care

    4. RXL ProShares Ultra Health Care ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 8 May 2012

      consider iShares Dow Jones U.S. Healthcare IYH (0.47% expense ratio), which is based ..... iShares Dow Jones U.S. Healthcare ETF IYH . As a result, this fund's daily returns ..... theoretically should be double the daily returns of IYH . Fundamental View Historically defensive

    5. BBH Market Vectors Biotech ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 17 Apr 2012

      return over that same period of 16.0%. By comparison, the popular broad U.S. health-care ETF iShares Dow Jones US Healthcare ETF IYH has had a volatility of return over the last 10 years of just 13.5%. Fundamental View To win regulatory

    6. IYH iShares Dow Jones US Healthcare ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Tue, 10 Apr 2012

      firms in the emerging-markets arena. IYH 's 0.47% expense ratio is low by mutual ..... performance 99% and 100% correlated with IYH during the past five years, respectively ..... charges. There is a heavy overlap between IYH 's holdings and XLV (which holds 51 names

    7. IHI iShares Dow Jones US Medical Devices ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Thu, 5 Apr 2012

      through broad health-care sector ETFs such as iShares Dow Jones US Healthcare IYH , Vanguard Health Care ETF VHT, and Health Care ..... correlated with IHI over the past five years, while IYH is 84% and XLV is 81%. Another option is to

    8. As The Supreme Court Mulls Health-Care Reform, The Sector Looks Cheap

      Headlines

      Wed, 28 Mar 2012

      By Morningstar : By Robert Goldsborough This week, the nine justices of the U.S. Supreme Court began hearing three days of oral arguments on what undoubtedly will be one of the most watched cases on the court's docket in decades: President Obama's health-care law. The court's ruling on whether some

    9. Checking Up On Healthcare ETFs: Valuations Remain Attractive

      Headlines

      Mon, 19 Mar 2012

      By Tom Lydon : The healthcare sector is facing a rough economic picture and headwinds that could adversely impact the exchange traded funds that track it. Key provisions have not yet been put into place, therefore, S&P Capital IQ Investment is giving the sector a marketweight rating. "The ...

    10. Lower Correlations Don't Mean That Active Managers Deserve Your Investment

      Headlines

      Thu, 16 Feb 2012

      By Symmetricinfo : A recent research piece by Oppenheimer talks about how the correlation within the stock market has reached a low after being elevated for the past two years. The piece argues that the recent decline in correlation coupled with their forecast that correlation is likely to remain

    « Prev123Next »
    Content Partners